Clinical trial
Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With…
NCT00035880 · Abgenix, Industry · Completed
Key facts
| NCT number | NCT00035880 |
|---|---|
| Title | Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease |
| Official title | A Phase II/III, Multicenter, Open Label, Randomized Clinical Trial Evaluating ABX-CBL When Compared to Atgam as Second Line Therapy in Patients With Steroid Resistant Acute Graft Versus Host Disease |
| Lead sponsor | Abgenix, Industry |
| Collaborators | Sangstat Medical Corporation Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Graft Vs Host Disease |
| Intervention type | Drug |
| Interventions | ABX-CBL |
| Enrollment | 95 |
| Start date | Oct 1, 1999 |
| Completion | Jun 1, 2003 |
| First posted | May 7, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: